DEGRADATION OF EXTRACELLULAR-MATRIX PROTEINS BY HUMAN CATHEPSIN-B FROM NORMAL AND TUMOR-TISSUES

被引:363
作者
BUCK, MR
KARUSTIS, DG
DAY, NA
HONN, KV
SLOANE, BF
机构
[1] WAYNE STATE UNIV,DEPT PHARMACOL,DETROIT,MI 48201
[2] WAYNE STATE UNIV,DEPT RADIAT ONCOL,DETROIT,MI 48201
[3] WAYNE STATE UNIV,DEPT CHEM,DETROIT,MI 48201
[4] HARPER GRACE HOSP,GERSHENSON RADIAT ONCOL,DETROIT,MI 48201
[5] GRACE HOSP,DETROIT,MI 48201
关键词
D O I
10.1042/bj2820273
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Our laboratory has previously demonstrated that increased malignancy of several histological types of human and animal tumours is associated with increases in their cathepsin B activity, particularly cathepsin B activity associated with plasma-membrane/endosomal vesicles or shed vesicles. Here we report that cathepsin B from normal or tumour tissues degrades purified extracellular-matrix components, type IV collagen, laminin and fibronectin, at both acid pH and neutral pH. The number and sizes of degradation products were analysed by SDS/PAGE. Cathepsin B from both sources exhibited similar activities towards, and similar patterns of cleavage of, the extracellular-matrix proteins. At neutral pH, cathepsin B from both sources appeared to undergo autodegradation, a process that was decreased in the presence of alternative substrates such as the extracellular-matrix proteins. Cathepsin B readily degraded type IV collagen at 25-degrees-C, indicating activity towards native type IV collagen. Fibronectin degradation products of 100-200 kDa and of 18 and 22 kDa were observed. A single 70 kDa fragment was released from laminin under non-reducing conditions and multiple fragments ranging from 45 to 200 kDa under reducing conditions. These results suggest that cathepsin B at or near the surface of malignant tumour cells may play a functional role in the focal dissolution of extracellular matrices.
引用
收藏
页码:273 / 278
页数:6
相关论文
共 36 条
[1]   L-TRANS-EPOXYSUCCINYL-LEUCYLAMIDO(4-GUANIDINO)BUTANE (E-64) AND ITS ANALOGS AS INHIBITORS OF CYSTEINE PROTEINASES INCLUDING CATHEPSINS B, H AND L [J].
BARRETT, AJ ;
KEMBHAVI, AA ;
BROWN, MA ;
KIRSCHKE, H ;
KNIGHT, CG ;
TAMAI, M ;
HANADA, K .
BIOCHEMICAL JOURNAL, 1982, 201 (01) :189-198
[2]   THE CYSTATINS - A NEW CLASS OF PEPTIDASE INHIBITORS [J].
BARRETT, AJ .
TRENDS IN BIOCHEMICAL SCIENCES, 1987, 12 (05) :193-196
[3]  
BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   CATHEPSIN-B1 - LYSOSOMAL ENZYME THAT DEGRADES NATIVE COLLAGEN [J].
BURLEIGH, MC ;
BARRETT, AJ ;
LAZARUS, GS .
BIOCHEMICAL JOURNAL, 1974, 137 (02) :387-+
[6]  
CHELBERG MK, 1990, J CELL BIOL, V111, P262
[7]  
GOTTESMAN MM, 1990, SEMIN CANCER BIOL, V1
[8]   MOLECULAR-CLONING OF MOUSE EPIDERMAL CYSTATIN-A AND DETECTION OF REGULATED EXPRESSION IN DIFFERENTIATION AND TUMORIGENESIS [J].
HAWLEYNELSON, P ;
ROOP, DR ;
CHENG, CK ;
KRIEG, TM ;
YUSPA, SH .
MOLECULAR CARCINOGENESIS, 1988, 1 (03) :202-211
[9]  
KERBEL R, 1990, CANCER METASTASIS RE, V9
[10]   ANTISENSE RNA INDUCED REDUCTION IN MURINE TIMP LEVELS CONFERS ONCOGENICITY ON SWISS 3T3-CELLS [J].
KHOKHA, R ;
WATERHOUSE, P ;
YAGEL, S ;
LALA, PK ;
OVERALL, CM ;
NORTON, G ;
DENHARDT, DT .
SCIENCE, 1989, 243 (4893) :947-950